Cyclosporin for treatment of refractory multisystemic inflammatory syndrome in a child.
Cardiol Young
; : 1-3, 2022 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: covidwho-20235782
ABSTRACT
Multisystemic inflammatory syndrome in children is an inflammatory condition with multiorgan dysfunction that manifest late in the course of Severe acute respiratory syndrome coronavirus 2 infection. We present a 12-year-old boy with a history of fever, vomiting, diarrhoea, and abdominal pain. He developed shock with ventricular dysfunction and pericardial effusion. He was diagnosed with multisystemic inflammatory syndrome in children and treatment with intravenous immunoglobulins, corticosteroids, and tocilizumab proved to be ineffective. Eventually, the patient responded to cyclosporin-A treatment. Multisystemic inflammatory syndrome in children has been treated with immunoglobulins and glucocorticoids and in refractory cases biologics and cyclosporin-A have been used. Intravenous and oral cyclosporin-A seems to be a safe and effective alternative treatment for refractory multisystemic inflammatory syndrome in children patients.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Tipo de estudio:
Estudio pronóstico
Idioma:
Inglés
Revista:
Cardiol Young
Asunto de la revista:
Angiología
/
Cardiología
/
Pediatría
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
S1047951122002748
Similares
MEDLINE
...
LILACS
LIS